会计年度:2021-12-31收入分布
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
合计 | 15,326,305,266.09 | 9,142,818,040.75 | 6,183,487,225.34 | 40.35 |
零售 | 14,087,364,808.77 | 8,467,040,252.79 | 5,620,324,555.98 | 39.90 |
批发 | 719,943,348.19 | 645,225,133.35 | 74,718,214.84 | 10.38 |
其他(补充) | 518,997,109.13 | 30,552,654.61 | 488,444,454.52 | 94.11 |
|
会计年度:2021-06-30
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
分部间抵销 | -1,751,114,961.57 | -1,542,758,848.80 | -208,356,112.77 | 11.90 |
合计 | 7,346,375,296.97 | 4,346,304,520.21 | 3,000,070,776.76 | 40.84 |
其他(补充) | 271,312,146.98 | 17,443,691.67 | 253,868,455.31 | 93.57 |
医药零售 | 6,746,858,289.16 | 4,035,126,827.05 | 2,711,731,462.11 | 40.19 |
医药批发 | 2,079,319,822.40 | 1,836,492,850.29 | 242,826,972.11 | 11.68 |
|
会计年度:2020-12-31
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
合计 | 13,144,502,415.77 | 8,152,070,753.40 | 4,992,431,662.37 | 37.98 |
零售 | 12,251,860,561.32 | 7,629,396,091.85 | 4,622,464,469.47 | 37.73 |
批发 | 561,488,111.05 | 499,042,841.42 | 62,445,269.63 | 11.12 |
其他(补充) | 331,153,743.40 | 23,631,820.13 | 307,521,923.27 | 92.86 |
|
会计年度:2020-06-30
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
分部间抵销 | 1,571,010,218.56 | 1,534,529,487.75 | 36,480,730.81 | 2.32 |
合计 | 6,292,859,200.53 | 3,896,484,526.86 | 2,396,374,673.67 | 38.08 |
其他(补充) | 165,051,627.33 | 9,502,173.99 | 155,549,453.34 | 94.24 |
医药零售 | 5,879,631,201.77 | 3,664,359,154.54 | 2,215,272,047.23 | 37.68 |
医药批发 | 1,819,186,589.99 | 1,757,152,686.08 | 62,033,903.91 | 3.41 |
|
会计年度:2019-12-31
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
合计 | 10,276,174,734.90 | 6,267,593,245.86 | 4,008,581,489.04 | 39.01 |
零售 | 9,589,279,937.13 | 5,892,868,600.14 | 3,696,411,336.99 | 38.55 |
批发 | 387,541,286.45 | 353,628,308.03 | 33,912,978.42 | 8.75 |
其他(补充) | 299,353,511.32 | 21,096,337.69 | 278,257,173.63 | 92.95 |
|